Agenus Needs Phase III For BOT/BAL, Another Example Of Shifting Accelerated Approval Climate

 
• By Alaric DeArment
  
The FDA clarified a Phase III and standard submission pathway for BOT/BAL. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards